Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis

Eur J Dermatol. 2014 Sep-Oct;24(5):618-9. doi: 10.1684/ejd.2014.2401.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Psoriasis / complications
  • Psoriasis / drug therapy*
  • Renal Dialysis
  • Renal Insufficiency, Chronic / complications
  • Renal Insufficiency, Chronic / therapy
  • Severity of Illness Index
  • Ustekinumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Ustekinumab